Format

Send to

Choose Destination
See comment in PubMed Commons below

[Comparison of early effectiveness between total percutaneous endovascular aneurysm repair and surgical femoral cutdown endovascular aneurysm repair for asymptomatic abdominal aortic aneurysm].

[Article in Chinese]

Author information

1
Department of Vascular Surgery, Vascular Surgery Center of Chinese PLA, General Hospital of Chinese PLA, Beijing, 100853, P.R.China.

Abstract

OBJECTIVE:

To investigate the early effectiveness of total percutaneous endovascular aneurysm repair (TPEVAR) in treating asymptomatic abdominal aortic aneurysm (AAAA) by comparing with surgical femoral cutdown endovascular aneurysm repair (SFCEVAR).

METHODS:

Between January 2010 and May 2011, 41 cases of AAAA were treated with TPEVAR in 26 cases (TPEVAR group) and with SFCEVAR in 15 cases (SFCEVAR group). The maximum tumor diameter ranged from 3.5 to 9.2 cm (mean, 5.7 cm) in TPEVAR group, and ranged from 3.5 to 10.0 cm (mean, 6.9 cm) in SFCEVAR group. There was no significant difference in gender or age between 2 groups (P > 0.05).

RESULTS:

All patients underwent EVAR successfully. The patients were followed up 6-23 months (mean, 13.5 months). No significant difference was found in the outer diameters of the delivery system for main body and iliac leg, operation time, contrast media dosage, hospitalization days, or postoperative hospitalization days between 2 groups (P > 0.05). The patients of SFCEVAR group had more bleeding volume and longer ICU stay than patients of TPEVAR group (P < 0.05). The incidence of minor complication was 7.7% (2/26) in TPEVAR group and 33.3% (5/15) in SFCEVAR group, showing no significant difference between 2 group (chi2=4.42, P=0.08); the incidence of major complication in SFCEVAR group (20.0%, 3/15) was significantly higher than that in TPEVAR group (0) (chi2=5.61, P=0.02).

CONCLUSION:

TPEVAR shows safer and more effective than SFCEVAR in treating AAAA.

PMID:
23230671
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center